Patents by Inventor Scott William Rowlinson

Scott William Rowlinson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Variants of human BMP7 protein
    Patent number: 11466066
    Abstract: The present invention relates to novel variants of human BMP7 protein. The invention embodies vectors and host cells for the propagation of nucleic acid sequences encoding said proteins and the production thereof. Also disclosed are methods for the treatment of cancer, cartilage damage and degeneration, pain associated with osteoarthritis, or bone healing.
    Type: Grant
    Filed: April 20, 2018
    Date of Patent: October 11, 2022
    Assignee: ELI LILLY AND COMPANY
    Inventors: James David Pancook, Scott William Rowlinson, Louis Frank Stancato
  • VARIANTS OF HUMAN BMP7 PROTEIN
    Publication number: 20210115100
    Abstract: The present invention relates to novel variants of human BMP7 protein. The invention embodies vectors and host cells for the propagation of nucleic acid sequences encoding said proteins and the production thereof. Also disclosed are methods for the treatment of cancer, cartilage damage and degeneration, pain associated with osteoarthritis, or bone healing.
    Type: Application
    Filed: April 20, 2018
    Publication date: April 22, 2021
    Inventors: James David Pancook, Scott William Rowlinson, Louis Frank Stancato
  • TGF-beta binding antibodies
    Patent number: 7927593
    Abstract: The present invention provides very high affinity antibodies, or antigen-binding fragments thereof, that neutralize mature human TGF-?1, TGF-?2, and TGF-?3. The antibodies of the invention are useful for treating cell proliferative disorders in a mammal.
    Type: Grant
    Filed: January 26, 2010
    Date of Patent: April 19, 2011
    Assignee: Eli Lilly and Company
    Inventors: Bryan Edward Jones, James David Pancook, Scott William Rowlinson
  • TGF-BETA BINDING ANTIBODIES
    Publication number: 20100136021
    Abstract: The present invention provides very high affinity antibodies, or antigen-binding fragments thereof, that neutralize mature human TGF-?1, TGF-?2, and TGF-?3. The antibodies of the invention are useful for mating cell proliferative disorders in a mammal.
    Type: Application
    Filed: January 26, 2010
    Publication date: June 3, 2010
    Applicant: ELI LILLY AND COMPANY
    Inventors: Bryan Edward Jones, James D. Pancook, Scott William Rowlinson
  • TGF-BETA BINDING ANTIBODIES
    Publication number: 20090155285
    Abstract: The present invention provides very high affinity antibodies, or antigen-binding fragments thereof, that neutralize mature human TGF-?1, TGF-?2, and TGF-?3. The antibodies of the invention are useful for treating cell proliferative disorders in a mammal.
    Type: Application
    Filed: February 6, 2009
    Publication date: June 18, 2009
    Inventors: Bryan Edward Jones, James D. Pancook, Scott William Rowlinson
  • TGF-? binding antibodies
    Patent number: 7494651
    Abstract: The present invention provides very high affinity antibodies, or antigen-binding fragments thereof, that neutralize mature human TGF-?1, TGF-?2, and TGF-?3. The antibodies of the invention are useful for treating cell proliferative disorders in a mammal.
    Type: Grant
    Filed: December 20, 2006
    Date of Patent: February 24, 2009
    Assignee: Eli Lilly and Company
    Inventors: Bryan Edward Jones, James D. Pancook, Scott William Rowlinson
  • Tgf-Beta Binding Antibodies
    Publication number: 20080292638
    Abstract: The present invention provides very high affinity antibodies, or antigen-binding fragments thereof, that neutralize mature human TGF-?1, TGF-?2, and TGF-?3. The antibodies of the invention are useful for treating cell proliferative disorders in a mammal.
    Type: Application
    Filed: December 20, 2006
    Publication date: November 27, 2008
    Inventors: Bryan Edward Jones, James D. Pancook, Scott William Rowlinson
  • Soluble proteins that inhibit cytokine signal transduction pathways
    Publication number: 20040204351
    Abstract: This invention provides methods using secreted IL10-related cytokine receptor subunits, and variants and fusions and combinations thereof for treating and preventing, inflammatory system, immune system, and cardiovascular system disorders as well as hematopoiesis disorders and cancer.
    Type: Application
    Filed: March 23, 2004
    Publication date: October 14, 2004
    Inventors: Scott William Rowlinson, David Bruce Baldwin
  • Lp mammalian proteins; related reagents
    Publication number: 20040152885
    Abstract: Isolated nucleic acid molecules encoding polypeptides from a human, reagents related thereto (including purified polypeptides specific antibodies) are provided. Methods of using said reagents and diagnostic kits are also provided.
    Type: Application
    Filed: August 27, 2003
    Publication date: August 5, 2004
    Inventors: Bernard Yaovi Amegadzie, Margaret Barbara Basinski, William L. Scott, Dayue Chen, Chongxi Huang, Gerald Patrick Keleher, Douglas Raymond Perkins, Paul Robert Rosteck, Scott William Rowlinson, Patanjali Raghavac Sankhavaram, Eugene Thomas Seno, Eric Wen Su, Yu Zhi
  • Lp mammalian proteins; related reagents
    Publication number: 20040126777
    Abstract: Isolated nucleic acid molecules encoding polypeptides from a human, reagents related thereto (including purified polypeptidesspecific antibodies) are provided. Methods of using said reagentsand diagnostic kits are also provided.
    Type: Application
    Filed: July 25, 2003
    Publication date: July 1, 2004
    Inventors: Ramesh Rajani Bhatt, John Nels Calley, Josef Georg Heuer, Gerald Patrick Keleher, Joanne Sloan Lancaster, Qingqin Li, Deshun Lu, Bradley Jay Mills, Santosh Kumar Mishra, Douglas Raymond Perkins, Scott William Rowlinson, Rosamund Carol Smith, Eric Wen Su, He Wang, Yu Zhi